Unicycive Therapeutics In... (UNCY)
Unicycive Therapeutics Statistics
Share Statistics
Unicycive Therapeutics has 120.63M shares outstanding. The number of shares has increased by -0.03% in one year.
| 120.63M |
| -0.03% |
| 0% |
| 69.37% |
| 100.03M |
| 20 |
| n/a |
Short Selling Information
The latest short interest is 356.9K, so 0.3% of the outstanding shares have been sold short.
| 356.9K |
| 0.3% |
| 0.31% |
| 1 |
Valuation Ratios
The PE ratio is -14.48 and the forward PE ratio is 3.86. Unicycive Therapeutics's PEG ratio is 0.15.
| -14.48 |
| 3.86 |
| 0 |
| 1.4 |
| 71.57 |
| -18.57 |
| 0.15 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Unicycive Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.1.
| 1.28 |
| 1.28 |
| 0.1 |
| -0.02 |
| -0.03 |
| -452.35 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,669,500 |
| 22 |
| 0 |
| n/a |
Taxes
| -1.09M |
| 2.89% |
Stock Price Statistics
The stock price has increased by 47.9% in the last 52 weeks. The beta is 2, so Unicycive Therapeutics's price volatility has been higher than the market average.
| 2 |
| 47.9% |
| 6.37 |
| 5.78 |
| 45.43 |
| 405,920 |
Balance Sheet
The company has 26.14M in cash and 773K in debt, giving a net cash position of 25.37M.
| 26.14M |
| 773K |
| 25.37M |
| -101.27M |
| 27.95M |
| 10.67M |
Cash Flow
In the last 12 months, operating cash flow was -28.57M and capital expenditures -72K, giving a free cash flow of -28.65M.
| -28.57M |
| -72K |
| -28.65M |
| -0.43 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
UNCY does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for UNCY is $60, which is 901.7% higher than the current price. The consensus rating is "Buy".
| $60 |
| 901.7% |
| Buy |
| 3 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Jun 20, 2025. It was a backward split with a ratio of 1:10.
| Jun 20, 2025 |
| backward |
| 1:10 |
Scores
| 21.11 |
| 2 |